"T1: tumour ≤2 cm in greatest dimension"
"T2: tumour >2 cm and ≤4 cm in greatest dimension"
"T3: tumour >4 cm in greatest dimension"
"T4: involvement of coeliac axis, superior mesenteric artery and/or common hepatic artery"
"Nx: nodes cannot be assessed"
"N0: no evidence of nodal involvement"
"N1: 1-3 regional node metastases present"
"Mx: presence of metastases cannot be assessed"
"M0: no evidence of metastases"
"M1: distant metastases present"
"stage 0: Tis N0 M0"
"stage Ia: T1 N0 M0"
"stage Ib: T2 N0 M0"
"stage IIa: T3 N0 M0"
"stage IIb: T1, T2, or T3 with N1 M0"
"stage III: N2 M0 with any T, or T4 with any N M0"
"stage IV: M1 with any T and N"
"Staging of pancreatic cancer (i.e. ductal adenocarcinoma) is traditionally performed according to the American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (UICC) TNM system."
"Staging of pancreatic cancer (i.e. ductal adenocarcinoma) is traditionally performed according to the American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (UICC) TNM system."
"Staging of pancreatic cancer (i.e. ductal adenocarcinoma) is traditionally performed according to the American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (UICC) TNM system."
"In the 2017 new edition (8th edition) AJCC published various major changes including exocrine and endocrine tumours of the pancreas are now staged using different staging systems. The following is for the staging of pancreatic adenocarcinoma. In the 8th edition of AJCC, T staging has become more size-based rather than descriptive-based, resectability has been omitted from T4 category, and the number and not just the presence of the regional lymph nodes defines the N stage of disease 1,3."
"In the 2017 new edition (8th edition) AJCC published various major changes including exocrine and endocrine tumours of the pancreas are now staged using different staging systems. The following is for the staging of pancreatic adenocarcinoma. In the 8th edition of AJCC, T staging has become more size-based rather than descriptive-based, resectability has been omitted from T4 category, and the number and not just the presence of the regional lymph nodes defines the N stage of disease 1,3."
"Tx, T0, Tis: see TNM system"
"Primary tumour staging (T)"
"Regional lymph nodes (N)"
"Metastases (M)"
"Tx, T0, Tis: see TNM system"
"T1a: tumour ≤0.5 cm in greatest dimension"
"T1b: tumour >0.5 cm and"
"T1c: tumour 1-2 cm in greatest dimension"
"Nx: nodes cannot be assessed"
Expected headings
"Primary tumour staging (T)"
"Regional lymph nodes (N)"
"Metastases (M)"
"Stage groupings"